Endolysin treatment against Staphylococcus aureus in adults with atopic dermatitis: a randomized controlled trial
Endolysin treatment against Staphylococcus aureus in this randomized vehicle-controlled trial was well tolerated, but had no topical corticosteroid sparing effect in patients with atopic dermatitis. The effective run-in with corticosteroids may have influenced the results.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Jill de Wit, Joan E.E. Tott é, Minke M.F. van Mierlo, Joyce van Veldhuizen, Martijn B.A. van Doorn, Frank H.J. Schuren, Sten P. Willemsen, Luba M. Pardo, Suzanne G.M.A. Pasmans Source Type: research
More News: Allergy | Allergy & Immunology | Corticosteroid Therapy | Dermatitis | Dermatology | Staphylococcus Aureus